- Home
- PRTG vs HBIO Comparison
PRTG vs HBIO Comparison
Compare PRTG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- HBIO
- Stock Information
- Founded
- PRTG 1973
- HBIO 1901
- Country
- PRTG British Virgin Islands
- HBIO United States
- Employees
- PRTG N/A
- HBIO N/A
- Industry
- PRTG Oil & Gas Production
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- PRTG Energy
- HBIO Industrials
- Exchange
- PRTG Nasdaq
- HBIO Nasdaq
- Market Cap
- PRTG 17.7M
- HBIO 19.6M
- IPO Year
- PRTG N/A
- HBIO 2000
- Fundamental
- Price
- PRTG $5.91
- HBIO $0.45
- Analyst Decision
- PRTG
- HBIO Buy
- Analyst Count
- PRTG 0
- HBIO 2
- Target Price
- PRTG N/A
- HBIO $3.00
- AVG Volume (30 Days)
- PRTG 231.6K
- HBIO 1.2M
- Earning Date
- PRTG 08-26-2025
- HBIO 08-11-2025
- Dividend Yield
- PRTG N/A
- HBIO N/A
- EPS Growth
- PRTG N/A
- HBIO N/A
- EPS
- PRTG N/A
- HBIO N/A
- Revenue
- PRTG N/A
- HBIO $91,397,000.00
- Revenue This Year
- PRTG N/A
- HBIO N/A
- Revenue Next Year
- PRTG N/A
- HBIO $9.75
- P/E Ratio
- PRTG N/A
- HBIO N/A
- Revenue Growth
- PRTG N/A
- HBIO N/A
- 52 Week Low
- PRTG $2.10
- HBIO $0.28
- 52 Week High
- PRTG $23.01
- HBIO $3.48
- Technical
- Relative Strength Index (RSI)
- PRTG 45.85
- HBIO 49.68
- Support Level
- PRTG $5.60
- HBIO $0.39
- Resistance Level
- PRTG $6.20
- HBIO $0.48
- Average True Range (ATR)
- PRTG 0.42
- HBIO 0.03
- MACD
- PRTG 0.10
- HBIO -0.00
- Stochastic Oscillator
- PRTG 65.45
- HBIO 67.67
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.